ATE395101T1 - Pharmazeutische zusammensetzung, enthaltend proteine und/oder polypeptide sowie kolloidpartikel - Google Patents
Pharmazeutische zusammensetzung, enthaltend proteine und/oder polypeptide sowie kolloidpartikelInfo
- Publication number
- ATE395101T1 ATE395101T1 AT04727664T AT04727664T ATE395101T1 AT E395101 T1 ATE395101 T1 AT E395101T1 AT 04727664 T AT04727664 T AT 04727664T AT 04727664 T AT04727664 T AT 04727664T AT E395101 T1 ATE395101 T1 AT E395101T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptides
- proteins
- pharmaceutical composition
- polypeptide
- protein
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 7
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 102000004169 proteins and genes Human genes 0.000 title abstract 7
- 108090000623 proteins and genes Proteins 0.000 title abstract 7
- 239000002245 particle Substances 0.000 title abstract 5
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000000084 colloidal system Substances 0.000 title 1
- 102000001690 Factor VIII Human genes 0.000 abstract 2
- 108010054218 Factor VIII Proteins 0.000 abstract 2
- 229960000301 factor viii Drugs 0.000 abstract 2
- 108091035707 Consensus sequence Proteins 0.000 abstract 1
- 229920000954 Polyglycolide Polymers 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 229920001477 hydrophilic polymer Polymers 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 229920000747 poly(lactic acid) Polymers 0.000 abstract 1
- 239000004633 polyglycolic acid Substances 0.000 abstract 1
- 239000004626 polylactic acid Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46270103P | 2003-04-15 | 2003-04-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE395101T1 true ATE395101T1 (de) | 2008-05-15 |
Family
ID=33299976
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04727664T ATE395101T1 (de) | 2003-04-15 | 2004-04-15 | Pharmazeutische zusammensetzung, enthaltend proteine und/oder polypeptide sowie kolloidpartikel |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20070167359A1 (de) |
| EP (1) | EP1633440B1 (de) |
| JP (1) | JP2006523683A (de) |
| CN (1) | CN1774281B (de) |
| AT (1) | ATE395101T1 (de) |
| AU (1) | AU2004229253B2 (de) |
| BR (1) | BRPI0409424B8 (de) |
| CA (1) | CA2522179C (de) |
| DE (1) | DE602004013769D1 (de) |
| DK (1) | DK1633440T3 (de) |
| ES (1) | ES2307009T3 (de) |
| MX (1) | MXPA05010926A (de) |
| PL (1) | PL1633440T3 (de) |
| PT (1) | PT1633440E (de) |
| WO (1) | WO2004091723A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2554161A1 (de) | 2011-08-02 | 2013-02-06 | LFB Biotechnologies | Pharmazeutische Zusammensetzung enthaltend Faktor VII in Mizellen verkapselt |
| GB201417589D0 (en) | 2014-10-06 | 2014-11-19 | Cantab Biopharmaceuticals Patents Ltd | Pharmaceutical Formulations |
| GB201518170D0 (en) | 2015-10-14 | 2015-11-25 | Cantab Biopharmaceuticals Patents Ltd | Colloidal particles for subcutaneous administration with intravenous administration of therapeutic agent |
| GB201518171D0 (en) | 2015-10-14 | 2015-11-25 | Cantab Biopharmaceuticals Patents Ltd | Colloidal particles for topical administration with therapeutic agent |
| GB201518172D0 (en) * | 2015-10-14 | 2015-11-25 | Cantab Biopharmaceuticals Patents Ltd | Colloidal particles for use in medicine |
| US20220347113A1 (en) * | 2019-11-07 | 2022-11-03 | The Board Of Trustees Of The University Of Illinois | Peptides and methods of treating sepsis, atherosclerosis, thrombosis, stroke, heart attack and inflammation |
| CN115521603A (zh) * | 2021-06-24 | 2022-12-27 | 复旦大学 | 一种可原位相转变形成凝胶的组合物及其用途 |
| US20240058419A1 (en) * | 2022-08-22 | 2024-02-22 | Buddhist Tzu Chi Medical Foundation | Method for treating optic neuropathy |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4348384A (en) * | 1980-10-17 | 1982-09-07 | Dainippon Pharmaceutical Co., Ltd. | Pharmaceutical composition for oral administration containing coagulation factor VIII or IX |
| DE68925966T2 (de) * | 1988-12-22 | 1996-08-29 | Kirin Amgen Inc | Chemisch modifizierte granulocytenkolonie erregender faktor |
| US5013556A (en) * | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5225212A (en) * | 1989-10-20 | 1993-07-06 | Liposome Technology, Inc. | Microreservoir liposome composition and method |
| US5527528A (en) * | 1989-10-20 | 1996-06-18 | Sequus Pharmaceuticals, Inc. | Solid-tumor treatment method |
| US5766897A (en) * | 1990-06-21 | 1998-06-16 | Incyte Pharmaceuticals, Inc. | Cysteine-pegylated proteins |
| JPH0482839A (ja) * | 1990-07-20 | 1992-03-16 | Green Cross Corp:The | 蛋白質類・脂質小体複合体 |
| NZ260909A (en) * | 1993-07-05 | 1995-04-27 | Takeda Chemical Industries Ltd | Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution |
| US5874075A (en) * | 1993-10-06 | 1999-02-23 | Amgen Inc. | Stable protein: phospholipid compositions and methods |
| US5705483A (en) * | 1993-12-09 | 1998-01-06 | Eli Lilly And Company | Glucagon-like insulinotropic peptides, compositions and methods |
| WO1995021629A1 (en) * | 1994-02-08 | 1995-08-17 | Amgen Inc. | Oral delivery of chemically modified proteins |
| US5512549A (en) * | 1994-10-18 | 1996-04-30 | Eli Lilly And Company | Glucagon-like insulinotropic peptide analogs, compositions, and methods of use |
| DE69800640T2 (de) * | 1997-01-29 | 2001-07-05 | Polymasc Pharmaceuticals Plc, London | Pegylationsverfahren |
| DE69922189T2 (de) * | 1998-04-27 | 2005-11-10 | Opperbas Holding B.V. | Pharmazeutische zusammensetzungen enthaltend faktor viii und neutrale liposomen |
| JP2003505401A (ja) * | 1999-07-14 | 2003-02-12 | アルザ・コーポレーション | 中性リポポリマーとそれを含有するリポソーム組成物 |
| AU2001238469C1 (en) * | 2000-02-18 | 2006-08-24 | Yeda Research And Development Co., Ltd. | Oral, nasal and pulmonary dosage formulations of copolymer 1 |
| WO2002086117A1 (en) * | 2001-04-20 | 2002-10-31 | The University Of Vermont | Compositions and methods to control bleeding |
| EP1461014B1 (de) * | 2001-12-04 | 2021-07-14 | Ben Gurion University Of The Negev Research And Development Authority | Amphiphile verbindungen und vesikel/liposome für das organspezifische arzneimittel-targeting |
-
2004
- 2004-04-15 AT AT04727664T patent/ATE395101T1/de not_active IP Right Cessation
- 2004-04-15 WO PCT/IL2004/000327 patent/WO2004091723A1/en active IP Right Grant
- 2004-04-15 PT PT04727664T patent/PT1633440E/pt unknown
- 2004-04-15 US US10/553,357 patent/US20070167359A1/en not_active Abandoned
- 2004-04-15 DK DK04727664T patent/DK1633440T3/da active
- 2004-04-15 BR BRPI0409424A patent/BRPI0409424B8/pt not_active IP Right Cessation
- 2004-04-15 AU AU2004229253A patent/AU2004229253B2/en not_active Expired
- 2004-04-15 CN CN2004800100998A patent/CN1774281B/zh not_active Expired - Lifetime
- 2004-04-15 MX MXPA05010926A patent/MXPA05010926A/es active IP Right Grant
- 2004-04-15 CA CA2522179A patent/CA2522179C/en not_active Expired - Fee Related
- 2004-04-15 EP EP04727664A patent/EP1633440B1/de not_active Expired - Lifetime
- 2004-04-15 ES ES04727664T patent/ES2307009T3/es not_active Expired - Lifetime
- 2004-04-15 JP JP2006507607A patent/JP2006523683A/ja active Pending
- 2004-04-15 DE DE602004013769T patent/DE602004013769D1/de not_active Expired - Lifetime
- 2004-04-15 PL PL04727664T patent/PL1633440T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0409424A (pt) | 2006-04-25 |
| CA2522179A1 (en) | 2004-10-28 |
| BRPI0409424B8 (pt) | 2021-05-25 |
| JP2006523683A (ja) | 2006-10-19 |
| CA2522179C (en) | 2012-02-14 |
| CN1774281A (zh) | 2006-05-17 |
| DK1633440T3 (da) | 2008-09-08 |
| PL1633440T3 (pl) | 2008-12-31 |
| AU2004229253B2 (en) | 2009-11-05 |
| ES2307009T3 (es) | 2008-11-16 |
| BRPI0409424B1 (pt) | 2018-05-02 |
| PT1633440E (pt) | 2008-08-25 |
| US20070167359A1 (en) | 2007-07-19 |
| EP1633440B1 (de) | 2008-05-14 |
| WO2004091723A1 (en) | 2004-10-28 |
| EP1633440A1 (de) | 2006-03-15 |
| MXPA05010926A (es) | 2005-11-25 |
| AU2004229253A1 (en) | 2004-10-28 |
| CN1774281B (zh) | 2010-10-13 |
| DE602004013769D1 (de) | 2008-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE450548T1 (de) | Rgd-angereicherte gelatineähnliche proteine mit verstärkter zellbindung | |
| DE69922189D1 (de) | Pharmazeutische zusammensetzungen enthaltend faktor viii und neutrale liposomen | |
| AU6819294A (en) | Oral drug delivery compositions and methods | |
| EP1778842B8 (de) | Zusammensetzungen und verfahren zur verwendung von mgd-cdf zur krankheitsbehandlung | |
| MY129566A (en) | A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance | |
| DK1137400T3 (da) | Præparater indeholdende et peptid og polymælkesyre-glycolsyre egnet til fremstilling af subkutane implantater med en forlænget frigivelsesperiode | |
| ATE206308T1 (de) | Arzneizusammensetzungen enthaltend ein bakterizides permeabilität erhöhendes protein und ein tensid | |
| DE69426019D1 (de) | Stabile bakterizide proteine, welche die permeabilität erhöhen und pharmazeutische zusammensetzungen, diese enthaltend | |
| CA2499014A1 (en) | Lactoferrin compositions and methods of wound treatment | |
| JP2006131648A (ja) | コラーゲンベースの注入可能な薬剤送達製剤およびその使用 | |
| EP2711025A3 (de) | Selbstangeordnete Peptide mit Modifikationen und Verwendungsverfahren dafür | |
| ATE187740T1 (de) | Modifizierte proteine und peptide enthaltende pharmazeutische mittel | |
| ATE191615T1 (de) | Aminosäurenzusammensetzungen und verwendung derselben klinischen nährung | |
| ATE395101T1 (de) | Pharmazeutische zusammensetzung, enthaltend proteine und/oder polypeptide sowie kolloidpartikel | |
| BR0009472A (pt) | Antagonistas de lhrh com propriedades desolubilidade aperfeiçoadas | |
| ATE549036T1 (de) | Thymosin-alpha-1-peptid/polymer-konjugate | |
| DK0523330T3 (da) | Implanterbare sammensætninger indeholdende et biologisk aktivt protein, peptid eller polypeptid | |
| NZ591827A (en) | Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating immune reaction in a radiotherapy-induced immuno-compromised subject | |
| Sutherland et al. | Biocompatibility and immunogenic response to recombinant honeybee silk material | |
| DE60329115D1 (de) | Tumorantigenprotein und dessen verwendung | |
| Ali et al. | Marine collagen: promising biomaterial in delivery of therapeutics for cancer therapy | |
| KR102218427B1 (ko) | 단백질 약물을 포함하는 코아세르베이트 조성물 및 이를 포함하는 창상 치료제 | |
| WO2004032863A3 (en) | Oral formulations for proteins and polypeptides | |
| EP1862170A1 (de) | Proteinformulierung | |
| MX9604539A (es) | Aminoacidos modificados para la distribucion de farmaco. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1633440 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |